Back to series
Finerenone in chronic kidney disease and type 2 diabetes: A FIDELITY analysis of left ventricle hypertrophy
Prof. Gerasimos Filippatos

Finerenone in chronic kidney disease and type 2 diabetes: A FIDELITY analysis of left ventricle hypertrophy

Prof. Gerasimos Filippatos
Expected completion time: 15 mins
0.25 CPD Credit

Late Breaking Clinical Trial - Presented at #ESC HF 2022

Sign up to start learning
,